Offer - Urjas Oil for just ₹ 1 X
Glitaris M 15 Tablet SR is a prescription medicine that is available as a Tablet. The alternative uses of Glitaris M 15 Tablet SR have also been explained below.
The correct dosage of Glitaris M 15 Tablet SR depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Common side effects of Glitaris M 15 Tablet SR include Stomach Upset, Difficulty urinating, Muscle Ache. While these are the most often observed Glitaris M 15 Tablet SR side effects, there are can be others also. These have been listed below. Such side effects of Glitaris M 15 Tablet SR normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Glitaris M 15 Tablet SR's effect during pregnancy is Moderate and Moderate while nursing. In addition, Glitaris M 15 Tablet SR's effects on the liver, heart and kidney are discussed below in the Glitaris M 15 Tablet SR related warnings section.
Glitaris M 15 Tablet SR can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Glitaris M 15 Tablet SR in conditions like Congestive Heart Failure (CHF), Anemia, Shock. Other conditions have been mentioned below in the Glitaris M 15 Tablet SR contraindications section.
Drug interactions for Glitaris M 15 Tablet SR have been reported in the medical literature. A complete list of these interactions is given below.
In addition to the above precautions for Glitaris M 15 Tablet SR, it is important to know that it is safe while driving, and is habit-forming.
Glitaris M 15 Tablet SR is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Glitaris M 15 Tablet SR safe for pregnant women?
Glitaris M can have harmful effects in pregnant women. If you experience any discomfort after using Glitaris M, then discontinue the use and take your doctor's advice.
Is the use of Glitaris M 15 Tablet SR safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Glitaris M. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Glitaris M 15 Tablet SR on the Kidneys?
Glitaris M may have mild side effects on the kidneys.
What is the effect of Glitaris M 15 Tablet SR on the Liver?
Glitaris M may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Glitaris M 15 Tablet SR on the Heart?
You may experience side effects on your heart after taking Glitaris M. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
If you are suffering from any of the following diseases, you should not take Glitaris M 15 Tablet SR unless your doctor advises you to do so -
Is this Glitaris M 15 Tablet SR habit forming or addictive?
Forming a habit of Glitaris M 15 Tablet SR has not been reported.
Interaction between Food and Glitaris M 15 Tablet SR
Due to the absence of research, it is difficult to say how Glitaris M 15 Tablet SR and food will interact.
Interaction between Alcohol and Glitaris M 15 Tablet SR
Taking Glitaris M 15 Tablet SR and alcohol together may cause some problems. If you notice any of these side effects, it is best to go to your doctor.
Yes, Glitaris M can cause some sleep problems, especially insomnia. On the other hand, Glitaris M has proven to be useful for preventing sleep apnea. The exact relationship between Glitaris M and sleep problems is still not clear, and further studies are needed for a clearer understanding.
Glitaris M helps in weight loss by reducing appetite and food intake. It also increases the insulin sensitivity in your body to work more effectively. This lead to decreased glucose production increases the use of glucose and decrease the fat deposition further helps in weight loss. However, Glitaris M is not approved for weight loss, this is an off-label use.
Yes, Glitaris M can be taken with the statin. There is no serious or harmful interaction have been observed between them. Some studies say that it's possible your blood sugar (blood glucose) level may increase when you take a statin, which may lead to developing type 2 diabetes. The risk is small but important enough that the Food and Drug Administration (FDA) has issued a warning on statin labels regarding blood glucose levels and diabetes.
Yes, Glitaris M can cause night sweat, the exact mechanism of sweating is not known. But some research suggests that Glitaris M causes hypoglycemia (low blood sugar) especially at night which can cause night sweats. Need to monitor your blood glucose level regularly, and talk to your doctor as your dose of Glitaris M may need to be adjusted.
Yes, Glitaris M is safe to use, many people have side effects at first, they usually diminish and then go away completely in a few weeks. A few people find they cannot tolerate metformin, there are other drugs but metformin is usually the first choice. It is very safe
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033